36 Treatment of Parasitic Infections
Albendazole (Albenza) (Amedra)
Amphotericin B (AmBisome) (Gilead)
Amphotericin B (Fungizone) (X-Gen)
Artemether (Artenam) (Aarenco, Belgium)
Atovaquone (Mepron) (GlaxoSmithKline)
Atovaquone-proguanil (Malarone) (GlaxoSmithKline)
Benznidazole (Rochagan) (Roche, Brazil)
Bithionol (Bitin) (CDC)
Chloroquine phosphate (Aralen) (Sanofi, others)
Crotamiton (Eurax) (Ranbaxy)
Dapsone (Jacobus)
Diethylcarbamazine citrate USP (Hetrazan) (CDC)
Diloxanide furoate (Furamide, Entamide) (Boots, England)
Eflornithine (difluoromethylornithine, Ornidyl) (Sanofi) (CDC)
Fumagillin (Fumidil-B)
Furazolidone (Furoxone)
Iodoquinol/diiodohydroxyquin (Yodoxin) (Glenwood, others)
Ivermectin (Stromectol, Sklice) (Merck, Sanofi)
Lumefantrine/artemether (Coartem, Riamet) (Novartis)
Malathion (Ovide) (Taro Pharmaceuticals)
Mebendazole (generics)
Mefloquine hydrochloride (generics)
Melarsoprol (Mel-B) (CDC)
Metronidazole (Flagyl, IV Flagyl) (Searle/Pfizer, Baxter)
Miltefosine (Impavido, Miltex) (Paladin, Canada) (CDC)
Niclosamide (Yomesan, Niclocide) (Bayer, Germany)
Nifurtimox (Lampit) (Bayer HealthCare) (CDC)
Nitazoxanide (Alinia) (Romark)
Paromomycin (generics) (Sun Pharma)
Pentamidine isethionate (Pentam 300, Nebupent) (APP Pharmaceuticals)
Permethrin (Nix [Insight Pharmaceuticals], Elimite [Prestium Pharma])
Polyhexamethylene biguanide (Baquacil) (Zeneca)
Praziquantel (Biltricide) (Bayer)
Primaquine phosphate (Sanofi-Aventis)
Propamidine isethionate (Brolene) (Aventis, Canada)
Pyrantel pamoate (Pin-X, Reese’s Pinworm Medicine) (Quartz Specialty Pharmaceuticals, Reese)
Pyrethrin with piperonyl butoxide (Rid) (Bayer, others)
Pyrimethamine (Daraprim) (Amedra)
Quinidine gluconate (generics)
Quinine sulfate or quinine dihydrochloride (many manufacturers)
Spiramycin (Rovamycine) (Sanofi-Aventis)
Stibogluconate sodium (Pentostam, Solustibosan) (GlaxoSmithKline) (CDC)
Suramin sodium (Germanin) (Bayer, Germany) (CDC)
Thiabendazole (Mintezol) (Merck)
Tinidazole (Tindamax) (Mission Pharmaceuticals)
Triclabendazole (Egaten) (Novartis)
A1.1 Classification of human parasites
A1.2 Distribution of selected parasitic infections in the Americas
A1.3 Distribution of selected parasitic infections in Europe
A1.4 Distribution of selected parasitic infections in Africa
A1.5 Distribution of selected parasitic infections in Asia
A1.6 Distribution of selected parasitic infections in Oceania
A1.7 Cosmopolitan distribution of common parasitic infections (North America, Mexico, Central America, South America, Europe, Africa, Asia, and Oceania)
A1.8 Body sites and specimen collection
A1.9 Body sites and possible parasites recovered (trophozoites, cysts, oocysts, spores, adults, larvae, eggs, amastigotes, and trypomastigotes)
A1.10 Body site, specimen and procedures, recommended methods, relevant parasites, and comments
A1.11 Examination of tissue and body fluids
A1.12 Key characteristics of protozoa of the intestinal tract and urogenital system
A1.13 Key characteristics of tissue protozoa
A1.14 Key characteristics of helminths
A1.15 Key characteristics of most common parasites found in blood
A1.16 Diagnostic laboratory report information that should be relayed to the physician
A1.17 Pros and cons of stool specimen collection and testing options
A1.18 Approaches to stool parasitology: test ordering
A1.19 Pros and cons of ova and parasite examination options
A1.20 Laboratory test reports: optional comments
A1.21 Estimated prevalence of parasitic diseases worldwide
APPENDIX 2 Flowcharts and Staining Tables for Diagnostic Procedures
Flowcharts
A2.1 Procedure
